Breaking News on Contract Research, Manufacturing & Clinical Trials

Big Sponsors > Bayer

Evotec reaches pre-clinical milestone in Bayer alliance

23-May-2017 - Evotec AG has received a payment of approximately ‎€5m ($5.62m) as part of its strategic alliance with Bayer – which the company says is “well on track and very successful.”

CRO Evotec sees spin-out firm as strategic opportunity

12-May-2016 - Evotec’s auto-immune spin-out Topas represents “a strategic opportunity” for the CRO, which reported strong first quarter sales this week.

Dispatches from PCT

Patient-centric trials to give CROs competitive edge, say sponsors

19-Nov-2015 - A more patient-focused approach will expedite clinical trials and responsive CROs will have the competitive advantage, say AstraZeneca, EMD and Bayer.

German CRO joins tenants on Bayer campus

22-Sep-2015 - Preclinical CRO NMI TT Pharmaservices is establishing a branch at Bayer’s campus in Germany.

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told the preclinical CRO may add scale to US...

News in brief

Bayer manufactures for biologics start-up in CoLaborator project

26-Feb-2015 - Bayer has announced a strategic alliance to manufacture a preclinical candidate for small biotech Aronora.

PPD’s X-Chem signs multi-target collaboration with Janssen

12-Jan-2015 - PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.  

European CRO Evotec cashes in on strategic partnerships

23-Dec-2014 - Contract drug developer Evotec AG has achieved multiple milestones resulting in €8m ($9.8m) in revenue thanks to its collaborations with Bayer and Janssen Pharmaceuticals.

PPD’s X-Chem licenses cardiovascular drug discovery program to Bayer

19-Dec-2014 - PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012. 

Covance says investor lawsuit seeking to derail LabCorp acquisition ‘without merit’

15-Dec-2014 - A Covance investor is raising questions over Goldman Sachs’ involvement in providing advice to the CRO’s board, which recently accepted a $6.1bn takeover offer from industry peer LabCorp.

Mercks & recreation? The pharma industry and the sporting world

03-Nov-2014 - In an Outsourcing-Pharma sporting special, we reveal why GSK will not be at the Rio Olympics, why PPD has renewed its ironman triathlon sponsorship, and what became of BMS' partnership with Lance...

Some positive milestone news for Evotec: Bayer collaboration enters animal testing

01-Oct-2014 - Evotec has announced positive milestone news this week, revealing that efforts to develop an endometriosis drug with Bayer have moved into preclinical testing.

Bayer teams with Cenix in RNAi tech discovery deal

05-May-2014 - Bayer has inked a deal with preclinical CRO Cenix BioScience to use its genome-scale RNA interference (RNAi) platform to target an undisclosed disease.

Bayer Clinical Units to be Transferred to Outsourcing Partner CRS

24-Jun-2013 - Pharma companies may be moving away from global CROs and towards more specialised early phase partners, according to German firm CRS who has inked a partnership deal with Bayer.

DKSH's Cambodian Services Deal with Bayer Gets 5 Year Extension

21-Mar-2013 - DKSH says its contract extension with Bayer in Cambodia strengthens its position as a service provider for pharmaceutical companies throughout Southeast Asia.

Bayer CRO consolidation sets up Covance for rise in revenue

19-Jun-2012 - Bayer could spend up to 50 per cent more with Covance after it cuts ties with its other late phase CRO partner.

Covance inks alliances with Bayer and Eli Lilly

31-May-2012 - Covance has inked deals to provide preclinical services to Eli Lilly’s diabetes operations in China and late-stage support to Bayer Healthcare.

Bayer adds mutational analyses to Prometheus’ service deal

09-Dec-2010 - Prometheus Laboratories is performing mutational analyses on clinical samples from Bayer Schering Pharma as part of an extended services agreement.

News in brief

Algeta to supply Bayer; plans manufacturing expansion

26-Jul-2010 - Algeta has signed a deal making it the exclusive supplier of Alpharadin (radium-223) to Bayer, prompting the expansion of the production facility at IFE.

Bayer’s engineering affiliate opens up in India

01-Apr-2009 -  Bayer Technology Services GmbH, an affiliate of Germany's Bayer, has opened its first regional office in India, enlarging its presence in the fast-growing Asian markets.  

Bayer, Biocon discuss potential R&D and outsourcing deal

04-Oct-2007 - German pharma firm Bayer is currently discussing with Indian company Biocon about a potential deal that would include the co-development of new biologics with an outsourcing element, according to Biocon.

Bayer, Novartis settle Betaseron battle

17-Sep-2007 - Novartis and Bayer Schering Pharma have finally settled their disputes over multiple sclerosis (MS) drug Betaseron (interferon beta-1b), with an agreement outlined in March now complete.

Bayer pipeline in good shape as merger rumours build

21-Aug-2007 - Analysts believe Bayer's research and development pipeline is well equipped to deal with looming patent expiries but that didn't stop rumours of a Novartis buyout last week.

Nuvelo restarts alfimeprase development but Bayer bails out

27-Jun-2007 - Six months after a couple of failed Phase III trials, Nuvelo has reinstated clinical development for its blood clot dissolving drug, but it will have to go it alone after...

Bayer cuts swathe through pipeline

19-Jun-2007 - In the inevitable reshuffle that comes after a major acquisition, Bayer's healthcare division has today announced plans to cut 30 per cent of its drug pipeline.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...